<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03867916</url>
  </required_header>
  <id_info>
    <org_study_id>184511</org_study_id>
    <secondary_id>NCI-2018-02196</secondary_id>
    <nct_id>NCT03867916</nct_id>
  </id_info>
  <brief_title>Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients</brief_title>
  <official_title>The Patient Cancer OUtreach, Navigation, Technology, and Support (Patient COUNTS) Project: Addressing Care for Asian Americans With Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bristol-Myers Squibb Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This phase I/II trial studies how well patient portal and navigation program work in&#xD;
      providing information for Asian American cancer patients. Patient portal and navigation&#xD;
      program may help to improve the care provided to Asian American cancer patients.This study is&#xD;
      offered in the following languages in addition to English: Chinese (Cantonese or Mandarin)&#xD;
      and Vietnamese.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:&#xD;
&#xD;
      I. Identify Asian American adults newly diagnosed with colorectal, liver, or lung cancer&#xD;
      using a population-based cancer registry.&#xD;
&#xD;
      II. Conduct outreach to these patients to let them know about the availability of information&#xD;
      on these cancers, the Patient Cancer OUtreach, Navigation, Technology and Support (COUNTS)&#xD;
      web portal, and the Patient COUNTS patient navigation program.&#xD;
&#xD;
      III. Provide patient navigation either virtually or in-person.&#xD;
&#xD;
      OUTLINE:&#xD;
&#xD;
      Patients attend focus groups to help develop patient portal and navigation program. Patients&#xD;
      use in-person navigation program. In phase II, patients use an online portal to access&#xD;
      navigation program and may choose to have online/virtual navigation support or in-person&#xD;
      navigation support. Patients also complete data collection and surveys over 15 minutes via&#xD;
      web portal at baseline, 3 months, and 6 months and user experience survey at end of program&#xD;
      participation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 13, 2018</start_date>
  <completion_date type="Anticipated">April 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of Participation</measure>
    <time_frame>Any time between consent and month 6</time_frame>
    <description>At least one contact with patient navigator</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adherence to Guideline Treatment</measure>
    <time_frame>Month 6</time_frame>
    <description>Positive response(s) to survey item(s) on completion of MD-recommended treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Acceptability</measure>
    <time_frame>Month 7</time_frame>
    <description>Response of &quot;satisfied&quot; or &quot;very satisfied&quot; to survey item on satisfaction with Patient COUNTS navigation program</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">203</enrollment>
  <condition>Caregiver</condition>
  <condition>Malignant Neoplasm</condition>
  <condition>Physician</condition>
  <condition>Stage I Colorectal Cancer AJCC v8</condition>
  <condition>Stage I Liver Cancer</condition>
  <condition>Stage I Lung Cancer AJCC v8</condition>
  <condition>Stage IA1 Lung Cancer AJCC v8</condition>
  <condition>Stage IA2 Lung Cancer AJCC v8</condition>
  <condition>Stage IA3 Lung Cancer AJCC v8</condition>
  <condition>Stage IB Lung Cancer AJCC v8</condition>
  <condition>Stage II Colorectal Cancer AJCC v8</condition>
  <condition>Stage II Liver Cancer</condition>
  <condition>Stage II Lung Cancer AJCC v8</condition>
  <condition>Stage IIA Colorectal Cancer AJCC v8</condition>
  <condition>Stage IIA Lung Cancer AJCC v8</condition>
  <condition>Stage IIB Colorectal Cancer AJCC v8</condition>
  <condition>Stage IIB Lung Cancer AJCC v8</condition>
  <condition>Stage IIC Colorectal Cancer AJCC v8</condition>
  <condition>Stage III Colorectal Cancer AJCC v8</condition>
  <condition>Stage III Liver Cancer</condition>
  <condition>Stage III Lung Cancer AJCC v8</condition>
  <condition>Stage IIIA Colorectal Cancer AJCC v8</condition>
  <condition>Stage IIIA Lung Cancer AJCC v8</condition>
  <condition>Stage IIIB Colorectal Cancer AJCC v8</condition>
  <condition>Stage IIIB Lung Cancer AJCC v8</condition>
  <condition>Stage IIIC Colorectal Cancer AJCC v8</condition>
  <condition>Stage IIIC Lung Cancer AJCC v8</condition>
  <arm_group>
    <arm_group_label>Health services research (Patient COUNTS)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients attend focus groups to help develop patient portal and navigation program. Patients use in-person navigation program. Patients also complete data collection and surveys over 15 minutes via web portal at baseline, 3 months, and 6 months and user experience survey at end of program participation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Patient Navigation Program</intervention_name>
    <description>Use patient navigation program</description>
    <arm_group_label>Health services research (Patient COUNTS)</arm_group_label>
    <other_name>Patient Navigator Program</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Quality-of-Life Assessment</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Health services research (Patient COUNTS)</arm_group_label>
    <other_name>Quality of Life Assessment</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Survey Administration</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Health services research (Patient COUNTS)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  FOR INTERVIEWS AND FOCUS GROUPS:&#xD;
&#xD;
               -  Cancer patients: Self-identifies as Asian American, lives in San Francisco,&#xD;
                  speaks English, Mandarin, Cantonese, or Vietnamese, has a history of cancer of&#xD;
                  any kind&#xD;
&#xD;
               -  Caregivers: any person age 21 and older who has provided care to an Asian&#xD;
                  American cancer patient&#xD;
&#xD;
               -  Health professionals: physicians and other health professionals age 21 and older&#xD;
                  who provide care to Asian American patients with cancer&#xD;
&#xD;
          -  FOR PILOT IMPLEMENTATION:&#xD;
&#xD;
               -  Self-identifies as Asian American&#xD;
&#xD;
               -  Ages 21 or older&#xD;
&#xD;
               -  Lives in the 9 counties of the greater bay area cancer registry (GBACR)&#xD;
&#xD;
               -  Speaks English, Mandarin, Cantonese, or Vietnamese&#xD;
&#xD;
               -  Has any stage colorectal, lung, or liver cancer&#xD;
&#xD;
               -  Has not started treatment or has not completed treatment&#xD;
&#xD;
               -  Is willing to stay in the study for six months.&#xD;
&#xD;
          -  FOR FULL IMPLEMENTATION:&#xD;
&#xD;
               -  Self-identifies as Asian American&#xD;
&#xD;
               -  Ages 21 or older&#xD;
&#xD;
               -  Lives in the 9 counties of the GBACR&#xD;
&#xD;
               -  Speaks English, Mandarin, Cantonese, or Vietnamese&#xD;
&#xD;
               -  Has any stage colorectal, lung, or liver cancer,&#xD;
&#xD;
               -  Has not started or has not completed treatment&#xD;
&#xD;
               -  Is willing to stay in the study for six-seven months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        *Any medical or psychological conditions precluding informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tung T Nguyen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laura Allen</last_name>
    <phone>415-514-3423</phone>
    <email>Laura.Allen@ucsf.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94158</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Allen</last_name>
      <phone>415-514-3423</phone>
      <email>laura.allen@ucsf.edu</email>
    </contact>
    <contact_backup>
      <phone>877-827-3222</phone>
      <email>cancertrials@ucsf.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Tung T. Nguyen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>March 6, 2019</study_first_submitted>
  <study_first_submitted_qc>March 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2019</study_first_posted>
  <last_update_submitted>October 26, 2021</last_update_submitted>
  <last_update_submitted_qc>October 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Liver Neoplasms</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

